Wait Times for Scheduling Appointments for Prevention of Macrovascular and Microvascular Complications of Diabetes: Cross-Sectional Descriptive Study

被引:1
作者
Basch, Corey H. [1 ,4 ]
Hillyer, Grace C. [2 ]
Basch, Charles E. [3 ]
机构
[1] William Paterson Univ, Dept Publ Hlth, Wayne, NJ USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[3] Columbia Univ, Dept Hlth Studies & Appl Educ Psychol, Teachers Coll, New York, NY USA
[4] William Paterson Univ, Dept Publ Hlth, Univ Hall, Wayne, NJ 07470 USA
关键词
appointment scheduling; cardiologists; chronic disease; cross-sectional study; diabetes; endocrinologists; healthcare utilization; lifestyle modification; management plan; metabolic control; online booking; ophthalmologists; prevention; quality of life; scheduling appointments; scheduling; specialist; timeliness; United States; wait time; well-being; HEALTH-CARE; CLINICAL INERTIA; ACCESS;
D O I
10.2196/55351
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Diabetes is a chronic disease that requires lifelong management and care, affecting around 422 million people worldwide and roughly 37 million in the United States. Patients newly diagnosed with diabetes must work with health care providers to formulate a management plan, including lifestyle modifications and regular office visits, to improve metabolic control, prevent or delay complications, optimize quality of life, and promote well-being. Objective: Our aim is to investigate one component of system -wide access to timely health care for people with diabetes in New York City (NYC), namely the length of time for someone with newly diagnosed diabetes to obtain an appointment with 3 diabetes care specialists: a cardiologist, an endocrinologist, and an ophthalmologist, respectively. Methods: We contacted the offices of 3 different kinds of specialists: cardiologists, endocrinologists, and ophthalmologists, by telephone, for this descriptive cross-sectional study, to determine the number of days required to schedule an appointment for a new patient with diabetes. The sampling frame included all specialists affiliated with any private or public hospital in NYC. The number of days to obtain an appointment with each specialist was documented, along with "time on hold" when attempting to schedule an appointment and the presence of online booking capabilities. Results: Of the 1639 unique physicians affiliated with (private and public) hospitals in the 3 subspecialties, 1032 (cardiologists, endocrinologists, and ophthalmologists) were in active practice and did not require a referral. The mean wait time for scheduling an appointment was 36 (SD 36.4; IQR 12-51.5) days for cardiologists; 82 (SD 47; IQR 56-101) days for endocrinologists; and 50.4 (SD 56; IQR 10-72) days for ophthalmologists. The median wait time was 27 days for cardiologists, 72 days for endocrinologists, and 30 days for ophthalmologists. The mean time on hold while attempting to schedule an appointment with these specialists was 2.6 (SD 5.5) minutes for cardiologists, 5.4 (SD 4.3) minutes for endocrinologists, and 3.2 (SD 4.8) minutes for ophthalmologists, respectively. Over 46% (158/341) of cardiologists enabled patients to schedule an appointment on the web, and over 55% (128/228) of endocrinologists enabled patients to schedule an appointment on the web. In contrast, only approximately 25% (117/463) of ophthalmologists offered web -based appointment scheduling options. Conclusions: The results indicate considerable variation in wait times between and within the 3 specialties examined for a new patient in NYC. Given the paucity of research on wait times for newly diagnosed people with diabetes to obtain an appointment with different specialists, this study provides preliminary estimates that can serve as an initial reference. Additional research is needed to document the extent to which wait times are associated with complications and the demographic and socio-economic characteristics of people served by different providers.
引用
收藏
页数:7
相关论文
共 37 条
[1]   Nonadherence, Clinical Inertia, or Therapeutic Inertia? [J].
Allen, J. Daniel ;
Curtiss, Frederic R. ;
Fairman, Kathleen A. .
JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (08) :690-695
[2]   10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S144-S174
[3]  
American Diabetes Association, 2022, Clin Diabetes, V40, P10, DOI 10.2337/cd22-as01
[4]   Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review [J].
Andreozzi, F. ;
Candido, R. ;
Corrao, S. ;
Fornengo, R. ;
Giancaterini, A. ;
Ponzani, P. ;
Ponziani, M. C. ;
Tuccinardi, F. ;
Mannino, D. .
DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
[5]  
[Anonymous], 2022, WHAT IS DIAB
[6]  
[Anonymous], 2023, Number of active physicians in New York in 2023, by specialty area
[7]  
[Anonymous], 2023, Diabetes
[8]  
[Anonymous], 2023, New American Diabetes Association report finds annual costs of diabetes to be $412.9 billion
[9]  
[Anonymous], 2022, Cardiovascular disease and diabetes
[10]  
[Anonymous], 2023, Overcoming therapeutic inertia